The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials

By Yahoo! Finance   |   1 year ago
The Weight Loss Drug Race Heats Up: Eli Lilly's Zepbound Outperforms Wegovy in Weight Loss Trials

Eli Lilly's Zepbound has outperformed Novo Nordisk's Wegovy in weight loss trials. Zepbound targets adults with obesity and comorbidities.

Read More

Did you find this insightful?